| Non-CAD group (n = 92) | CAD group (n = 252) | p value |
---|---|---|---|
Male (%) | 48 (52.2) | 165 (65.5) | 0.025 |
Age (years) | 61 ± 9 | 65 ± 9 | < 0.001 |
Cigarette smoking (%) | 19 (20.7) | 91 (36.1) | 0.007 |
Hypertension (%) | 56 (60.9) | 177 (70.2) | NS |
Blood pressure | Â | Â | Â |
   Systolic (mmHg) | 123 ± 17 | 126 ± 20 | NS |
   Diastolic (mmHg) | 76 ± 8 | 78 ± 9 | NS |
Hyperlipidemia (%) | 48 (52.2) | 154 (61.1) | NS |
Duration of diabetes (months) | 58 ± 68 | 78 ± 77 | 0.022 |
Oral anti-hyperglycemic therapy (%) | 42 (45.7) | 111 (44.0) | NS |
Insulin (%) | 33 (35.9) | 103 (40.9) | NS |
Statins (%) | 57 (61.9) | 175 (69.4) | NS |
Cholesterol | Â | Â | Â |
   Total cholesterol (mmol/L) | 4.6 ± 1.1 | 4.8 ± 1.2 | NS |
   LDL-C (mmol/L) | 2.7 ± 0.8 | 2.9 ± 1.0 | NS |
   HDL-C (mmol/L) | 1.0 ± 0.2 | 1.1 ± 0.3 | NS |
Triglycerides (mmol/L) | 2.1 ± 1.2 | 2.2 ± 1.6 | NS |
Creatinine (μmol/L) | 77 ± 19 | 87 ± 23 | < 0.001 |
eGFR (ml/min/1.73 m2) | 87 ± 23 | 79 ± 18 | < 0.001 |
Fasting plasma glucose (mmol/L) | 7.3 ± 1.8 | 7.6 ± 2.4 | NS |
Hemoglobin A1c (%) | 7.5 ± 1.4 | 7.6 ± 1.5 | NS |
MAGE (mmol/L) | 3.2 ± 1.2 | 3.7 ± 1.4 | < 0.001 |
MODD (mmol/L) | 2.4 ± 1.0 | 2.5 ± 1.0 | NS |
PPGE (mmol/L) | 3.6 ± 1.4 | 3.9 ± 1.6 | 0.036 |
BMI (kg/m2) | 26.0 ± 2.2 | 26.4 ± 2.4 | NS |
hs-CRP (mg/L) | 5.8 ± 6.7 | 10.7 ± 12.4 | < 0.001 |